爱沙尼亚结核分枝杆菌耐药克隆的时空分布研究
该研究分析了2014年北爱沙尼亚(含塔林)新诊断结核患者的结核分枝杆菌分离株,进行药敏试验、耐药突变检测及谱系/克隆分型。结果显示39.8%为北京基因型,其中56.8%为MDR;北京B0/W148簇的MDR比例显著高于其他北京株(81.8% vs 20.0%,P=0.0007)。
要点
- 北京基因型占39.8%,其中56.8%为MDR,非北京基因型(LAM、Haarlem、Ural)主要敏感。
- 北京B0/W148簇的MDR比例显著高于其他北京株(81.8% vs 20.0%,P=0.0007)。
- rpoB S531L、katG S315T和embB M306V为最常见耐药突变。
核心结论
- 北京B0/W148簇近20年活跃传播,是爱沙尼亚结核控制的主要威胁。
- MDR相关北京株中rpoB531和katG315突变占绝对优势,需关注。
研究设计与样本
- 研究纳入2014年北爱沙尼亚(含塔林)新诊断结核患者的M. tuberculosis分离株。
- 对分离株进行一线和二线药敏试验、rpoB、katG、inhA、rrs、embB和gyrA突变检测及谱系/克隆特异性基因分型。
主要发现
- 39.8%的分离株为北京基因型,其中56.8%为MDR。
- 所有三种主要非北京基因型(LAM、Haarlem和Ural)主要对药物敏感。
- 北京B0/W148簇的MDR比例(81.8%)显著高于其他北京分离株(20.0%;P=0.0007)。
- 8株为pre-XDR表型,其中6株属于北京B0/W148。
- 所有利福平耐药和氧氟沙星耐药株及97%的异烟肼耐药株分别携带rpoB、gyrA和katG耐药突变;rpoB S531L、katG S315T和embB M306V突变最常见。
临床怎么用
- 对北京基因型尤其是B0/W148簇结核株应加强耐药监测。
- 重点关注rpoB S531L和katG S315T突变以快速识别MDR相关耐药。
局限性
- 研究仅纳入2014年北爱沙尼亚新诊断患者,样本代表性有限。
- 未报告样本量及置信区间等详细统计信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We assessed the genetic structure of the Mycobacterium tuberculosis population in Estonia with a special focus on major epidemic/endemic clones and drug resistance determinants. We investigated the hypothesis of the decisive impact of massive human influx on the locally circulating genotypes. Estonia received a mass immigration from Russia during 1945-90 followed by enhanced interaction with the EU since 1991. METHODS: The study sample included M. tuberculosis isolates from patients newly diagnosed with TB in 2014 in North Estonia (including the capital Tallinn). The isolates were subjected to first- and second-line drug susceptibility testing, detection of mutations in rpoB, katG, inhA, rrs, embB and gyrA and lineage/clone-specific genotyping. RESULTS: Of the M. tuberculosis isolates, 39.8% were assigned to the Beijing genotype; 56.8% of them were MDR. In contrast, all three major non-Beijing genotypes (LAM, Haarlem and Ural) were mainly drug susceptible. MDR was more prevalent among Beijing B0/W148-cluster isolates (81.8%) compared with other Beijing isolates (20.0%; P = 0.0007). The pre-XDR phenotype was found in eight isolates, of which six belonged to Beijing B0/W148. All rifampicin-resistant and ofloxacin-resistant and 97% of isoniazid-resistant isolates harboured resistance mutations in rpoB, gyrA and katG. The rpoB S531L, katG S315T and embB M306V mutations were the most prevalent. CONCLUSIONS: The major pool of the Beijing isolates was brought to Estonia before 1990. However, an active circulation of the most hazardous MDR-associated Beijing B0/W148-cluster started only in the last 20 years and its significantly increased circulation presents the major threat to TB control in Estonia. The overwhelming prevalence of the rpoB531 and katG315 mutations in the MDR-associated Beijing isolates requires attention.
引用
- Vyazovaya A, Levina K, Zhuravlev V, et al. Emerging resistant clones of Mycobacterium tuberculosis in a spatiotemporal context. J Antimicrob Chemother. 2018. PMID: 29092043. doi:10.1093/jac/dkx372
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。